- Companies
- Parallel
Parallel Funding, Investors & Competitors
Parallel has raised $190M across 5 funding rounds, most recently a $100M Series D in June 2019.
Last Parallel funding round
$100M
Series D · Jun 2019
Cumulative funding Parallel raised
$190M
across 5 funding rounds
Key investors in Parallel
Edward Brown
About Parallel
Parallel is a Florida-based cannabis company that cultivates, processes, and distributes medical marijuana products through its network of dispensaries. Operating under the Curaleaf brand, it produces flower, concentrates, edibles, and topicals compliant with state regulations. Parallel serves patients via 25 retail locations across Florida, emphasizing quality control and strain-specific therapies.
Founded
2014
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Product sales
Parallel Funding History
Parallel has raised a total of $190M across 5 funding rounds.
Parallel's first fundraising round was a $10M Series A in December 2015. The most recent completed round was a $100M Series D in June 2019.
Parallel funding rounds
| Date | Stage | Investors | Raised |
|---|---|---|---|
| Jun 2019 | Series D | Edward Brown (lead) | $100M |
| Aug 2018 | Series C | - | $65M |
| May 2017 | Series A | - | $5M |
| Dec 2016 | Series B | - | $10M |
| Dec 2015 | Series A | - | $10M |
Who has invested in Parallel?
1 investor has backed Parallel across its funding rounds, including Edward Brown.
Lead investors include Edward Brown.
Parallel Investors
| Investor | Rounds | Role | First check |
|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 Parallel investors. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Parallel
Parallel has acquired 3 companies to date.
Last acquisition by Parallel was on April 1st 2021. Parallel acquired Windy City Cannabis for $100M.
Latest Acquisitions by Parallel
| Description | Windy City Cannabis operates four licensed medical cannabis dispensaries among Illinois's 60 total permits. The dispensaries serve communities in Chicago's southwest suburbs through locations in Justice, Lombard, and Romeoville. | Molecular Infusions is a biopharmaceutical company advancing synthetic cannabinoid formulations for pain management and epilepsy. Its liposomal delivery systems improve bioavailability of THC and CBD, with Phase 2 trials underway in Canada. | New England Treatment Access is a Massachusetts-based vertically integrated cannabis company with retail dispensaries in Brookline and Northampton, plus cultivation and processing facilities in Franklin. NETA produces over 250 stock-keeping units including flower, edibles, and concentrates. The company holds multiple licenses in the state's recreational and medical markets. |
| HQ Country | |||
| HQ City | Chicago, IL | Nashville, TN | Boston, MA |
| Deal Date | 1 Apr 2021 | 25 Jun 2019 | 14 Jan 2019 |
| Valuation | $100M | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Parallel acquisitions and their M&A valuation multiples. Start Free Trial | |||
Parallel Competitors
Parallel competitors include listed companies like Curaleaf, Trulieve Cannabis and Green Thumb Industries, and private ones like Dutchie, Accelerant and PAX Labs.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $45M | - | $3.8B | 83.3x | ||
| Publicly listed | $1.3B | $238M | $2.7B | 2.7x | ||
| Private | $913M | $282M | $2.4B | 2.6x | ||
| Publicly listed | $1.2B | $314M | $2.2B | 2.4x | ||
| Private | $113M | - | $1.7B | 15.0x | ||
| Publicly listed | $1.2B | $469M | $1.6B | 1.6x |
Parallel Public Comps
Parallel is still privately-owned, but its public comps include Curaleaf, Trulieve Cannabis, Green Thumb Industries, Cronos Group, Glass House Brands, Vireo Growth, Tilray Brands, Verano Holdings, Canopy Growth and SNDL.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1.3B | $238M | 2.8x | 2.7x | 14.9x | 12.6x | |||
| $1.2B | $314M | 2.1x | 2.4x | 7.9x | 6.7x | |||
| $1.2B | $469M | 1.6x | 1.6x | 4.0x | 5.9x | |||
| $147M | ($43M) | 3.3x | 2.6x | (11.3x) | 20.3x | |||
| $182M | $6M | 4.9x | 4.6x | 162.4x | 36.6x | |||
| $269M | $12M | 3.7x | 1.6x | 81.7x | 7.4x | |||
| $915M | $3M | 0.8x | 0.7x | 218.8x | 10.7x | |||
| $822M | $24M | 1.0x | 1.0x | 36.4x | 4.0x | |||
This data is available for Pro users. Sign up to see all Parallel competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Parallel
| When was Parallel founded? | Parallel was founded in 2014. |
| Where is Parallel headquartered? | Parallel is headquartered in Atlanta, GA, United States. |
| Is Parallel publicly listed? | No, Parallel is a private, VC-backed company. |
| How much funding has Parallel raised? | Parallel has raised $190M across 5 funding rounds. |
| What was Parallel's last funding round? | Parallel's last funding round was a $100M Series D in June 2019, led by Edward Brown. |
| Who are Parallel's investors? | Parallel's investors include Edward Brown. |
| Which companies are comparable to Parallel? | Companies comparable to Parallel include Dutchie, Curaleaf, Accelerant, Trulieve Cannabis, PAX Labs and Green Thumb Industries. |
| How many companies has Parallel acquired? | Parallel has acquired 3 companies, including Windy City Cannabis, Molecular Infusions and New England Treatment Access. |
| What was the largest acquisition by Parallel? | The $100M acquisition of Windy City Cannabis in April 2021 is the largest acquisition Parallel has made to date. |
See companies similar to Parallel
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




